Zhang Lab

University of Michigan

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	Muscarinic acetylcholine receptor M3
Species	Homo sapiens (Human)
Gene	CHRM3
Synonym	cholinergic receptor cholinergic receptor, muscarinic 3 cholinergic receptor, muscarinic 3, cardiac Chrm-3 HM4 M3 receptor M3R [ Show all ]
Disease	Urinary incontinence Overactive bladder Overactive bladder disorder Postoperative nausea and vomiting Respiratory disease Glaucoma Diagnosing bronchial hyperreactivity Chronic obstructive pulmonary disease Seborrhea Sjogren's syndrome Spasms; Pain Unspecified Alzheimer disease Obstructive lung diseases [ Show all ]
Length	590
Amino acid sequence	MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL
UniProt	P20309
Protein Data Bank	N/A
GPCR-HGmod model	N/A
3D structure model	No available structures or models
BioLiP	N/A
Therapeutic Target Database	T67684
ChEMBL	CHEMBL245
IUPHAR	15
DrugBank	BE0000045

Ligand

Name	pirenzepine
Molecular formula	C19H21N5O2
IUPAC name	11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one
Molecular weight	351.41
Hydrogen bond acceptor	5
Hydrogen bond donor	1
XlogP	0.1
Synonyms	SPBio_001494 Tox21_110239 DivK1c_000127 Gastrotsepin KBio2_004426 Lopac0_000962 11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one NCGC00015836-05 11-[2-(4-methylpiperazin-1-yl)ethanoyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride NCGC00024297-04 5,11-Dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one AKOS015969751 Prestwick1_000129 BSPBio_000178 C19H21N5O2 Spectrum3_001453 CTK6I3129 UNII-3G0285N20N DSSTox_RID_77049 GTPL328 KBioGR_000794 MLS000069702 11-[2-(4-methyl-1-piperazinyl)-1-oxoethyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride NCGC00015836-08 28797-61-7 PDSP1_000965 97P617 Pirenzepine [INN:BAN] BDBM39341 Pyrenzepine SCHEMBL41705 CCG-205042 Spectrum_001378 FT-0600051 KBio1_000127 L000485 NCGC00015836-03 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one NCGC00015836-12 3G0285N20N Pirenzepina AB00053603_09 Pirenzepinum [INN-Latin] BRD-K89375097-300-06-2 SPBio_002117 CHEMBL9967 Tox21_110239_1 DSSTox_CID_3487 Gastrozepin KBio2_006994 LS-133128 11-[(4-Methyl-1-piperazinyl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one # NCGC00015836-06 11-[2-(4-methylpiperazino)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride NCGC00024297-05 6H-Pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)- Pirenzepine (INN) API0006928 Prestwick2_000129 BSPBio_002945 CAS-28797-61-7 Spectrum4_000437 D08389 ZINC19632927 DTXSID7023487 HMS2089K21 KBioSS_001858 NCGC00015836-01 11-[2-(4-Methyl-piperazin-1-yl)-acetyl]-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one NCGC00015836-09 PDSP2_000949 AB00053603 pirenzepinedihydrochloride BPBio1_000196 RMHMFHUVIITRHF-UHFFFAOYSA-N SMR000058502 CHEBI:8247 Tocris-1071 DB00670 Gasteril KBio2_001858 Lopac-P-7412 NCGC00015836-04 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride NCGC00024297-02 5,11-Dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one Pirenzepina [INN-Spanish] AC1L1J3B Prestwick0_000129 BRN 0628987 C07508 Spectrum2_001417 cid_185248 Ulcosan DSSTox_GSID_23487 Gastrozepin (TN) KBio3_002445 LS-519 11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one NCGC00015836-07 2-[2-(4-methylpiperazin-1-yl)acetyl]-2,4,9-triazatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one NINDS_000127 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]- Pirenzepine Gastrozepin BCP12188 Prestwick3_000129 CAS-29868-97-1 Spectrum5_001344 D0T0LM EINECS 249-228-4 IDI1_000127 L-S 519 NCGC00015836-02 11-[2-(4-methylpiperazin-1-yl)-acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one NCGC00015836-10 Pirenzepin AB00053603-08 Pirenzepinum BRD-K89375097-300-05-4 SBI-0050935.P003 [ Show all ]
Inchi Key	RMHMFHUVIITRHF-UHFFFAOYSA-N
Inchi ID	InChI=1S/C19H21N5O2/c1-22-9-11-23(12-10-22)13-17(25)24-16-7-3-2-5-14(16)19(26)21-15-6-4-8-20-18(15)24/h2-8H,9-13H2,1H3,(H,21,26)
PubChem CID	4848
ChEMBL	CHEMBL9967
IUPHAR	328
BindingDB	39341
DrugBank	DB00670
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
IC50	955.6 nM	PMID9986705	ChEMBL
IC50	956.0 nM	PMID9986705	BindingDB
Ki	47.86 nM	PMID18595721	BindingDB,ChEMBL
Ki	125.893 nM	PMID8016895	PDSP
Ki	138.038 nM	PMID1994002	PDSP
Ki	138.04 nM	PMID1994002	BindingDB
Ki	150.0 nM	PMID1346637	PDSP,BindingDB
Ki	158.0 nM	PMID23379472	BindingDB,ChEMBL
Ki	158.489 - 316.228 nM	PMID12049493, PMID2704370, PMID7925952, PMID1994002, PMID9113359, PMID2043926	IUPHAR
Ki	180.0 nM	PMID2704370	PDSP,BindingDB
Ki	220.0 nM	PMID9121349	PDSP

zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218